Lidocaine Hydrochloride and Epinephrine Bitartrate
- Product NDC
- 51004-2010
- 11-digit product format
- 510042010
- Labeler code
- 51004
- Product ID
- 51004-2010_ba7ff05c-cdd8-4f17-a908-8e847ea35a75
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lidocaine Hydrochloride and Epinephrine Bitartrate
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Novocol Pharmaceutical of Canada, Inc.
- Application
- ANDA088390
- Marketing category
- ANDA
- Marketing start
- 2011-11-07
- Marketing end
- 0000-00-00
- Substance
- LIDOCAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
- Active strength
- 20 mg/mL; mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#